Cargando…

Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia

PURPOSE: To assess the proportion of adherence to topical anti-glaucoma medications and associated factors among glaucoma patients in Sidama regional state, Ethiopia. METHODS: An institution based cross-sectional study was conducted from May 30 to July 15, 2022 at Hawassa University comprehensive sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Melaku, Mekete Wodajnew, Yibekal, Betelhem Temesgen, Demilew, Ketemaw Zewdu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132528/
https://www.ncbi.nlm.nih.gov/pubmed/37099553
http://dx.doi.org/10.1371/journal.pone.0284200
_version_ 1785031400052752384
author Melaku, Mekete Wodajnew
Yibekal, Betelhem Temesgen
Demilew, Ketemaw Zewdu
author_facet Melaku, Mekete Wodajnew
Yibekal, Betelhem Temesgen
Demilew, Ketemaw Zewdu
author_sort Melaku, Mekete Wodajnew
collection PubMed
description PURPOSE: To assess the proportion of adherence to topical anti-glaucoma medications and associated factors among glaucoma patients in Sidama regional state, Ethiopia. METHODS: An institution based cross-sectional study was conducted from May 30 to July 15, 2022 at Hawassa University comprehensive specialized and Yirgalem General Hospitals in Sidama regional state, Ethiopia. A systematic random sampling method was used to select 410 study participants. An adapted eight-item self-reported questionnaire was used to assess adherence. Binary logistic regression was used to identify factors associated with adherence to topical anti-glaucoma medications. Variables with a p-value of <0.05 under multivariable analysis were taken as statistically significant factors for adherence. The strength of the association was measured by using an adjusted odds ratio with 95% confidence interval. RESULTS: A total of 410 participants were included giving a response rate of 98.3%. Those who were adherent to their medications were 221(53.9%) (95% CI: 48.8–58.5). Urban residence (AOR = 2.81: 95% CI = 1.34–5.87), higher educational level (AOR = 3.17: 95% CI = 1.24–8.09), monthly follow-up frequency (AOR = 3.30: 95% CI = 1.79–6.11) and normal vision (AOR = 6.58: 95% CI = 3.03–10.84) were significantly associated with adherence. CONCLUSION: More than half of glaucoma patients attending at Hawassa University comprehensive specialized and Yirgalem general hospitals were adherent to their topical anti-glaucoma medications. Urban residence, educational level, follow-up frequency, and normal vision were associated with adherence.
format Online
Article
Text
id pubmed-10132528
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-101325282023-04-27 Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia Melaku, Mekete Wodajnew Yibekal, Betelhem Temesgen Demilew, Ketemaw Zewdu PLoS One Research Article PURPOSE: To assess the proportion of adherence to topical anti-glaucoma medications and associated factors among glaucoma patients in Sidama regional state, Ethiopia. METHODS: An institution based cross-sectional study was conducted from May 30 to July 15, 2022 at Hawassa University comprehensive specialized and Yirgalem General Hospitals in Sidama regional state, Ethiopia. A systematic random sampling method was used to select 410 study participants. An adapted eight-item self-reported questionnaire was used to assess adherence. Binary logistic regression was used to identify factors associated with adherence to topical anti-glaucoma medications. Variables with a p-value of <0.05 under multivariable analysis were taken as statistically significant factors for adherence. The strength of the association was measured by using an adjusted odds ratio with 95% confidence interval. RESULTS: A total of 410 participants were included giving a response rate of 98.3%. Those who were adherent to their medications were 221(53.9%) (95% CI: 48.8–58.5). Urban residence (AOR = 2.81: 95% CI = 1.34–5.87), higher educational level (AOR = 3.17: 95% CI = 1.24–8.09), monthly follow-up frequency (AOR = 3.30: 95% CI = 1.79–6.11) and normal vision (AOR = 6.58: 95% CI = 3.03–10.84) were significantly associated with adherence. CONCLUSION: More than half of glaucoma patients attending at Hawassa University comprehensive specialized and Yirgalem general hospitals were adherent to their topical anti-glaucoma medications. Urban residence, educational level, follow-up frequency, and normal vision were associated with adherence. Public Library of Science 2023-04-26 /pmc/articles/PMC10132528/ /pubmed/37099553 http://dx.doi.org/10.1371/journal.pone.0284200 Text en © 2023 Melaku et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Melaku, Mekete Wodajnew
Yibekal, Betelhem Temesgen
Demilew, Ketemaw Zewdu
Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia
title Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia
title_full Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia
title_fullStr Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia
title_full_unstemmed Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia
title_short Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia
title_sort adherence to topical anti-glaucoma medications in sidama regional state, southern ethiopia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132528/
https://www.ncbi.nlm.nih.gov/pubmed/37099553
http://dx.doi.org/10.1371/journal.pone.0284200
work_keys_str_mv AT melakumeketewodajnew adherencetotopicalantiglaucomamedicationsinsidamaregionalstatesouthernethiopia
AT yibekalbetelhemtemesgen adherencetotopicalantiglaucomamedicationsinsidamaregionalstatesouthernethiopia
AT demilewketemawzewdu adherencetotopicalantiglaucomamedicationsinsidamaregionalstatesouthernethiopia